Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA

Heidi Overton has been nominated to lead the Food and Drug Administration at a moment of significant opportunity, but also big challenges. Innovation in medicine has never moved faster, providing more ways for Americans to improve their health and for the United States to advance the health of its population. But the institutions that carry that progress forward are under strain.

Overton has a chance to help bridge that divide — and the experience to do it. She has the opportunity to demonstrate these goals at Thursday’s confirmation hearing in front of the Senate health committee.

Read the full opinion.